ROSSINI, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 24.874
EU - Europa 22.952
AS - Asia 16.882
SA - Sud America 2.247
Continente sconosciuto - Info sul continente non disponibili 804
AF - Africa 462
OC - Oceania 41
Totale 68.262
Nazione #
US - Stati Uniti d'America 24.410
RU - Federazione Russa 7.720
SG - Singapore 7.084
GB - Regno Unito 5.408
CN - Cina 4.610
IT - Italia 2.970
BR - Brasile 1.762
HK - Hong Kong 1.472
DE - Germania 1.404
VN - Vietnam 1.360
FR - Francia 1.265
SE - Svezia 1.113
IE - Irlanda 1.066
FI - Finlandia 869
KR - Corea 558
BD - Bangladesh 401
IN - India 326
UA - Ucraina 315
TR - Turchia 230
CA - Canada 222
JP - Giappone 203
NL - Olanda 171
AR - Argentina 168
NG - Nigeria 132
MX - Messico 130
PL - Polonia 114
ES - Italia 112
IQ - Iraq 104
ID - Indonesia 96
ZA - Sudafrica 84
BE - Belgio 81
AT - Austria 76
EC - Ecuador 74
CO - Colombia 61
CL - Cile 51
PK - Pakistan 51
RO - Romania 47
UZ - Uzbekistan 47
VE - Venezuela 47
TG - Togo 43
BJ - Benin 39
MA - Marocco 37
IR - Iran 36
SA - Arabia Saudita 35
AU - Australia 33
NP - Nepal 30
PY - Paraguay 28
PH - Filippine 27
EG - Egitto 26
PE - Perù 26
KE - Kenya 25
CH - Svizzera 23
IL - Israele 23
LT - Lituania 22
JM - Giamaica 21
MY - Malesia 21
CZ - Repubblica Ceca 20
GR - Grecia 19
JO - Giordania 19
AZ - Azerbaigian 18
CR - Costa Rica 18
AE - Emirati Arabi Uniti 17
DZ - Algeria 16
TN - Tunisia 16
PT - Portogallo 15
BG - Bulgaria 14
BO - Bolivia 13
HR - Croazia 13
SK - Slovacchia (Repubblica Slovacca) 13
DO - Repubblica Dominicana 12
UY - Uruguay 12
KG - Kirghizistan 11
LB - Libano 11
OM - Oman 11
GT - Guatemala 10
HN - Honduras 10
AL - Albania 9
RS - Serbia 9
SV - El Salvador 9
BH - Bahrain 8
EU - Europa 8
LV - Lettonia 8
NO - Norvegia 8
PS - Palestinian Territory 8
QA - Qatar 8
SN - Senegal 8
DK - Danimarca 7
SI - Slovenia 7
TH - Thailandia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
ET - Etiopia 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PA - Panama 6
BY - Bielorussia 5
KW - Kuwait 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
BW - Botswana 4
Totale 67.361
Città #
Southend 4.776
Singapore 3.779
Ashburn 2.742
Moscow 2.468
Jacksonville 2.239
Chandler 2.205
San Jose 2.198
Dallas 1.801
Hong Kong 1.444
Woodbridge 1.234
Dublin 1.049
Council Bluffs 1.020
Ann Arbor 959
Verona 800
Beijing 731
The Dalles 724
Houston 703
New York 492
Los Angeles 477
Ho Chi Minh City 451
Lawrence 447
Princeton 447
Wilmington 426
Jinan 329
Nanjing 297
Hanoi 293
Shenyang 281
Buffalo 245
Milan 244
Redmond 238
Bologna 218
Helsinki 215
Santa Clara 191
Tokyo 184
Tianjin 182
Sindelfingen 178
Hebei 175
Munich 167
São Paulo 162
Redondo Beach 159
Changsha 136
Columbus 132
Abuja 128
Rome 124
Ningbo 113
Zhengzhou 113
Boardman 112
Haikou 109
Nanchang 108
Hangzhou 96
London 94
Orem 94
Warsaw 94
Seattle 91
Jiaxing 90
Guangzhou 88
Taizhou 88
Chicago 83
San Francisco 82
Denver 78
Phoenix 74
Redwood City 72
Brussels 69
Frankfurt am Main 69
Taiyuan 69
Norwalk 66
Falkenstein 65
Washington 65
Brooklyn 62
Montreal 62
Toronto 59
Turku 58
Da Nang 55
Atlanta 52
Johannesburg 52
Chennai 51
Falls Church 51
Amsterdam 50
Belo Horizonte 49
Hyderabad 49
Rio de Janeiro 49
Fairfield 48
Boston 45
Brasília 45
Mexico City 45
Tashkent 45
Vienna 45
Jakarta 44
Stockholm 44
Fuzhou 43
Lomé 43
Dearborn 42
Lanzhou 42
Manchester 42
Biên Hòa 41
Dong Ket 41
Orani 40
Cotonou 39
Poplar 39
Seoul 39
Totale 41.483
Nome #
Epidemiology and Economic Burden of Osteoporosis in Italy 454
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 426
Teriparatide and denosumab combination therapy and skeletal metabolism 353
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 337
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 276
Artrite Reumatoide e Metabolismo Minerale 274
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 274
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 270
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 268
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 258
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 257
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 257
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 247
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 246
Anti-CCP antibodies and bone 246
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 242
Age-related bone loss in postmenopausal women 239
[Therapeutic strategies in osteoporosis: whom and when to treat] 234
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 232
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 231
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 230
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 229
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 228
Bone metabolism in patients with anorexia nervosa and amenorrhoea 228
[Risk factors for hip fracture in elderly persons]. 225
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 224
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 220
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 220
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 216
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 216
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 212
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 211
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 211
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 210
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 209
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 208
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 208
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 208
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 207
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 206
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 205
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 204
Bone involvement and osteoporosis in mastocytosis. 204
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 204
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 200
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 200
Incidenza di ipovitaminosi D nel Nord Italia 199
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 194
Bone involvement in patient with clonal mast cell disorders 192
Prevalence and incidence of rheumatoid arthritis in Italy. 192
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 192
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 192
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 190
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 190
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 189
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 189
Could γ\δ T-cells explain zoledronic acid adverse events? 188
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 188
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 186
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 185
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 185
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 184
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 183
Guidelines for the diagnosis, prevention and management of osteoporosis 182
Osteopetrosi 181
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 181
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 181
Allergy and the bone: unexpected relationships 180
The obesity paradox and osteoporosis 180
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 179
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 178
Rapporti tra sistema immune e metabolismo osseo 177
Osteoporosis treatment: why ibandronic acid? 177
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 176
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 176
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 175
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 174
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 174
A multi-dimensional questionnaire quantifying quality of life in elderly osteoporotic women: the Italian triple-Q osteoporosis study 173
Bone Disease in Mastocytosis 173
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 173
ARTROPATIE DISMETABOLICHE 172
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 172
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 171
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 171
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 170
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 170
DXA bone mineral density in males: retrospective study in real life. 169
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 169
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 168
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 168
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 167
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 167
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 166
Sclerostin and DKK1 in primary hyperparathyroidism. 166
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 166
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 166
Association between environmental air pollution and rheumatoid arthritis flares 166
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 165
Obesity is not protective against fracture in postmenopausal women: GLOW 165
Totale 20.766
Categoria #
all - tutte 242.089
article - articoli 231.728
book - libri 0
conference - conferenze 3.338
curatela - curatele 0
other - altro 730
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.293
Totale 484.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.031 0 807 49 158 155 128 61 185 278 97 305 808
2022/20236.835 560 555 703 1.180 607 1.652 86 384 732 75 226 75
2023/20243.514 179 270 330 418 403 534 180 274 58 128 494 246
2024/20259.554 564 679 406 1.475 472 257 444 469 1.414 810 701 1.863
2025/202627.163 1.946 1.344 1.991 4.359 6.477 1.888 2.731 1.610 2.046 1.298 606 867
2026/20271.323 466 857 0 0 0 0 0 0 0 0 0 0
Totale 68.262